Early-life vitamin A treatment rescues neonatal infection-induced durably impaired tolerogenic properties of celiac lymph nodes

Cell Rep. 2024 May 28;43(5):114153. doi: 10.1016/j.celrep.2024.114153. Epub 2024 Apr 29.

Abstract

Gut-draining mesenteric and celiac lymph nodes (mLNs and celLNs) critically contribute to peripheral tolerance toward food and microbial antigens by supporting the de novo induction of regulatory T cells (Tregs). These tolerogenic properties of mLNs and celLNs are stably imprinted within stromal cells (SCs) by microbial signals and vitamin A (VA), respectively. Here, we report that a single, transient gastrointestinal infection in the neonatal, but not adult, period durably abrogates the efficient Treg-inducing capacity of celLNs by altering the subset composition and gene expression profile of celLNSCs. These cells carry information about the early-life pathogen encounter until adulthood and durably instruct migratory dendritic cells entering the celLN with reduced tolerogenic properties. Mechanistically, transiently reduced VA levels cause long-lasting celLN functional impairment, which can be rescued by early-life treatment with VA. Together, our data highlight the therapeutic potential of VA to prevent sequelae post gastrointestinal infections in infants.

Keywords: CP: Immunology; dendritic cells; long-lasting consequences; lymph node; neonatal gastrointestinal infections; regulatory T cells; stromal cells; vitamin A.

MeSH terms

  • Animals
  • Animals, Newborn
  • Dendritic Cells / immunology
  • Female
  • Immune Tolerance / drug effects
  • Lymph Nodes* / drug effects
  • Lymph Nodes* / immunology
  • Lymph Nodes* / pathology
  • Mice
  • Mice, Inbred C57BL
  • T-Lymphocytes, Regulatory* / drug effects
  • T-Lymphocytes, Regulatory* / immunology
  • Vitamin A* / pharmacology
  • Vitamin A* / therapeutic use

Substances

  • Vitamin A